We present a multifunctional nanoparticle platform that has targeting moieties shielded by a matrix metalloproteinase-2 (MMP2) cleavable PEG coating. Upon incubation with MMP2 this surface-switchable coating is removed and the targeting ligands become available for binding. The concept was evaluated in vitro using biotin and αvβ3-integrin-specific RGD-peptide functionalized nanoparticles.
No takes yet. Share an insight, caveat, or question.
Gianella et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: